Skip to main content
Fig. 1 | Pediatric Rheumatology

Fig. 1

From: Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial

Fig. 1

Study scheme with the patient flow chart. AE = adverse events, LFU = lost to follow-up, CWD = consent withdrawal, DC = diagnosis changed, CID = clinical inactive disease; ID = investigator decision; ETA = Etanercept, MTX = methotrexate

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096